prof. MUDr. Pavel Štourač, Ph.D.
Department vice-head, Department of Neurology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 3396 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 196
2020
-
The prevalence and characteristics of epilepsy in patients with relapsing-remitting multiple sclerosis treated with disease-modifying therapy
Ceska a slovenska neurologie a neurochirurgie, year: 2020, volume: 83, edition: 4, DOI
-
Validace dotazníku pro hodnocení dysfagie u pacientů s roztroušenou sklerózou - česká verze DYMUS
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, year: 2020, volume: 83, edition: 3, DOI
2019
-
Demyelinizace při dysregulaci imunitního systému u mladé pacientky
Year: 2019, type: Conference abstract
-
Initiation of first disease-modifying treatment for multiple sclerosis patients in the Czech republic from 2013 to 2016: Data from the national registry ReMuS
MULTIPLE SCLEROSIS AND RELATED DISORDERS, year: 2019, volume: 35, edition: OCT 2019, DOI
-
Prevalence a charakteristika epilepsie u pacientů s RRMS sklerózou léčených DMT.
Year: 2019, type: Conference abstract
-
Progresivní multifokální leukoencefalopatie - epidemiologie, imunitní odpověď, klinické rozdíly, léčba
Čs. epidemiologie, mikrobiologie, imunologie, year: 2019, volume: 68, edition: 1
-
Real world data comparing responders and non-responders for natalizumab treatment with using NEDA-3 and annual relapse rate (ARR)
Year: 2019, type: Appeared in Conference without Proceedings
-
The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings
MULTIPLE SCLEROSIS AND RELATED DISORDERS, year: 2019, volume: 30, edition: MAY 2019, DOI
-
Učebnice speciální neurologie
Year: 2019, type:
2018
-
Anti CD 20 terapie u roztroušené sklerózy
Neurologie pro praxi, year: 2018, volume: 19, edition: 1